No Data
No Data
Express News | NYSE Order Imbalance 64666.0 Shares on Sell Side
Orthopedic Implants Maker Zimmer Biomet Gains Analyst Upgrade Amid Promising Growth From New Products, Demographic Trends
Argus Research has upgraded Zimmer Biomet Holdings Inc. (NYSE:ZBH) on launching new products and tuck-in M&A to build future growth drivers. One such driver is the ROSA system, which assists in roboti
In-Depth Examination Of 6 Analyst Recommendations For Zimmer Biomet Holdings
During the last three months, 6 analysts shared their evaluations of Zimmer Biomet Holdings (NYSE:ZBH), revealing diverse outlooks from bullish to bearish.Summarizing their recent assessments, the tab
Zimmer Biomet Holdings Raised to Buy From Hold by Argus Research
Zimmer Biomet Holdings Raised to Buy From Hold by Argus Research
Express News | Argus Research Upgrades Zimmer Biomet Holdings to Buy, Announces $150 Price Target
Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
No Data